MYLAN I 400 (Imatinib Mesylate 400 mg)
Pill with imprint MYLAN I 400 is Orange, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Mylan Pharmaceuticals Inc..
Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN I 400
Imatinib Mesylate
- Imprint
- MYLAN I 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Bcr-abl tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2246
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related Images for "MYLAN I 400"
More about imatinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.